CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized mRNA cancer vaccine trial halted midway
Disease control TerminatedThis study tested a personalized mRNA vaccine (mRNA-4157) combined with the immunotherapy drug pembrolizumab for people with advanced skin cancer that could be removed by surgery. The goal was to see if the combination worked better than standard treatment or pembrolizumab alone.…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Scientists hunt for DNA markers to forecast lung cancer's next move
Knowledge-focused TerminatedThis study aimed to find genetic changes that could predict how a type of lung cancer (squamous cell carcinoma) progresses. Researchers planned to collect tissue and blood samples from 200 people with this cancer. The study was stopped early and only 22 people took part, so the r…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 06:49 UTC